Ad Banner Web

Synopsis: The board approved a 1:10 stock split on July 9, 2026, converting each Rs.10 face-value share into ten shares of Rs. 1 each, alongside the resignation of three directors, the appointment of three new directors, and a promoter reclassification request covering over 2 percent of the equity.

Investor interest is expected to rise following the approval of several corporate actions, including a significant stock split aimed at enhancing affordability and retail participation. The board also saw changes in leadership and a reclassification of certain stakeholders, reflecting a strategic shift in the company’s operations and governance.

With a market capitalization of approximately Rs. 267 crore, shares of Integrated Proteins Limited were trading around Rs. 142 on the BSE with a 52-week range of Rs. 155 to Rs. 20.71. It is trading at a P/E of 1,156. 

Stock Split and Capital Restructuring 

The board approved a Split of 1:10, converting each existing Rs.10 face-value equity share into ten shares of Rs.1 each, fully paid up. The record date will be announced once shareholder and regulatory approvals are in place, with completion expected within roughly two months. 

To effect the split, the board also approved altering the capital clause of the Memorandum of Association, though the authorized share capital stays unchanged at Rs.25 crore, now denominated as 25 crore shares of Rs.1 each instead of 2.5 crore shares of Rs.10. 

Board and Committee Changes

Alongside the capital restructuring, the company saw a leadership shuffle. Independent director Priyansh Tejas Parekh, non-executive director Neepa Praful Kothari, and executive director Vinod Prabhulal Mehta all resigned effective July 9, 2026, citing professional and personal commitments. 

Delta Exchange banner

The board appointed Nitish Pratapray Mehta and Hiren Dhirajlal Shah as additional executive directors, and Sandeep Mahadik as an additional non-executive independent director for a five-year term through June 2031, subject to shareholder approval. The Audit, Nomination and Remuneration, and Stakeholders’ Relationships Committees were also reconstituted accordingly. 

About Integrated Proteins Limited

Incorporated in 1992 and headquartered in Jamnagar, Gujarat, Integrated Proteins has traditionally been engaged in processing oilseeds such as soyabean, mustard, rapeseed and groundnut, supplying edible refined oil domestically while exporting de-oiled cake for use in animal feed. In recent periods, the company has also ventured into trading agricultural commodities. 

Financially, Integrated Proteins remains a micro-cap with a modest operating base: for the quarter ended March 2026, standalone sales stood at Rs.5.69 crore against Rs.5.47 crore in expenses, yielding an operating profit of Rs.0.22 crore and an operating margin of 3.87 percent, while net profit came in at Rs.0.19 crore with an EPS of Rs.0.10. For the full year FY26, standalone sales stood at Rs.9.94 crore, operating profit at Rs.0.27 crore, and net profit at Rs.0.23 crore, translating to an annual EPS of Rs.0.12. 

zerodha banner

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

  • Abhishek is a Junior Financial Analyst with over 5 years of experience in trading across equity markets. He has developed strong expertise in equity research, corporate actions, and stock market analysis. Currently preparing for the CFA program, he combines practical market experience with a growing academic foundation in finance. He actively tracks industry trends, rating agency updates, and company announcements, aiming to simplify complex financial concepts and deliver clear, concise, and research-driven insights for investors.

    Financial Analyst
× Ad Banner desktop Advertisement